期刊
CLINICA CHIMICA ACTA
卷 352, 期 1-2, 页码 37-47出版社
ELSEVIER
DOI: 10.1016/j.cccn.2004.09.019
关键词
organophosphates; paraoxonase (PON1); PON1 status; genetic susceptibility; biomarkers
资金
- NIA NIH HHS [T32-AG00057] Funding Source: Medline
- NIEHS NIH HHS [ES11397, ES07033, ES09601, ES04696, ES09883] Funding Source: Medline
Organophosphorus (OP) compounds are still among the most widely used insecticides, and their main mechanism of acute toxicity is associated with inhibition of acetylcholinesterase. Measurements of urine metabolites and of blood cholinesterase activity are established biomarkers of exposure to OPs and of early biological effects. In recent years, increasing attention has been given to biomarkers of susceptibility to OP toxicity. Here we discuss the polymorphisms of paraoxonase (PON1), a liver and serum enzyme that hydrolyzes a number of OP compounds, and its role in modulating the toxicity of OPs. We stress the importance of determining PON1 status, which encompasses the PON1(192)Q/R polymorphism (that affects catalytic ability toward different substrates) and PON1 levels (which are modulated in part by a C-108T polymorphism) over straight genotyping. Epidemiological studies on OP-exposed workers that include assessment of PON1 status to validate in human populations the role of PON1 as a determinant of susceptibility to OPs, as indicated by animal studies, are needed. Documentation of exposure and of early health effects would be most relevant to increase the predictive value of the test. (C) 2004 Elsevier B.V All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据